HTG Molecular Diagnostics(HTGMQ)
$0.000.00 (0.00%)
HTGMQ
HTG Molecular Diagnostics financials statements
$0.00
At close:0.00 (0.00%)
HTG Molecular Diagnostics (HTGMQ) Income Statement
457 Followers
HTG Molecular Diagnostics Income Statement
Last quarter (Q1 2023), HTG Molecular Diagnostics's total revenue was $1.03M, a decrease of 12.83% from the same quarter last year. In Q1, HTG Molecular Diagnostics's net income was $-5.05M. See HTG Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| $ 6.37M | $ 8.91M | $ 8.55M | $ 19.20M | $ 21.50M | |
| $ 1.79M | $ 4.81M | $ 4.56M | $ 10.29M | $ 16.41M | |
| $ 22.62M | $ 22.64M | $ 24.56M | $ 29.25M | $ 32.57M | |
| Depreciation and Amortization | $ 587.14K | $ 721.25K | $ 1.35M | $ 1.26M | $ 1.47M |
| $ -20.14M | $ -15.36M | $ -18.48M | $ -17.08M | $ -14.08M | |
| $ -20.83M | $ -17.82M | $ -19.59M | $ -18.96M | $ -16.16M | |
| $ -754.04K | $ 701.13K | $ -1.27M | $ -334.18K | $ -291.16K | |
| $ -21.58M | $ -17.12M | $ -20.86M | $ -19.29M | $ -16.45M | |
| $ -21.59M | $ -17.15M | $ -20.87M | $ -19.30M | $ -16.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ -24.28 | $ -29.66 | $ -54.12 | $ -91.17 | $ -107.61 |
| Diluted EPS | $ -24.28 | $ -29.66 | $ -54.12 | $ -91.17 | $ -107.61 |
| Weighted Average Shares Outstanding | 889.28K | 578.01K | 385.66K | 211.66K | 152.91K |
| Weighted Average Shares Outstanding (Diluted) | 889.28K | 578.01K | 385.66K | 211.66K | 152.91K |
Currency in USD
